You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

List of Excipients in API OXYMORPHONE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing OXYMORPHONE HYDROCHLORIDE

Glossary
CompanyTradenameIngredientNDCExcipientPotential Generic Entry
STAT Rx USA LLC OPANA oxymorphone hydrochloride 16590-765 D&C RED NO. 30
STAT Rx USA LLC OPANA oxymorphone hydrochloride 16590-765 LACTOSE MONOHYDRATE
STAT Rx USA LLC OPANA oxymorphone hydrochloride 16590-765 MAGNESIUM STEARATE
STAT Rx USA LLC OPANA oxymorphone hydrochloride 16590-765 STARCH, CORN
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry

Subscribe to access the full database, or Try for Free

Showing 1 to 4 of 4 entries

Excipients in ANDA-approved (generic) drugs containing OXYMORPHONE HYDROCHLORIDE

Detailed excipient profiles for OXYMORPHONE HYDROCHLORIDE

Excipient focus: ALUMINUM OXIDE

OXYMORPHONE HYDROCHLORIDE drug variants containing ALUMINUM OXIDE

Excipient focus: ANHYDROUS LACTOSE

OXYMORPHONE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE

OXYMORPHONE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

OXYMORPHONE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 30

Excipient focus: D&C YELLOW NO. 10

OXYMORPHONE HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

OXYMORPHONE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

OXYMORPHONE HYDROCHLORIDE drug variants not containing FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

OXYMORPHONE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

OXYMORPHONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

OXYMORPHONE HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSES

OXYMORPHONE HYDROCHLORIDE drug variants containing HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

OXYMORPHONE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

OXYMORPHONE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOLS

OXYMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

OXYMORPHONE HYDROCHLORIDE drug variants containing POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

OXYMORPHONE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

OXYMORPHONE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

OXYMORPHONE HYDROCHLORIDE drug variants not containing SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

OXYMORPHONE HYDROCHLORIDE drug variants containing SODIUM STEARYL FUMARATE

OXYMORPHONE HYDROCHLORIDE drug variants not containing SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

OXYMORPHONE HYDROCHLORIDE drug variants not containing STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

OXYMORPHONE HYDROCHLORIDE drug variants not containing STARCH, PREGELATINIZED CORN

Excipient focus: TALC

OXYMORPHONE HYDROCHLORIDE drug variants containing TALC

Excipient focus: TITANIUM DIOXIDE

OXYMORPHONE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group